<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0124-8146</journal-id>
<journal-title><![CDATA[Investigaciones Andina]]></journal-title>
<abbrev-journal-title><![CDATA[Investig. andina]]></abbrev-journal-title>
<issn>0124-8146</issn>
<publisher>
<publisher-name><![CDATA[Fundación Universitaria del Área Andina - FUNANDI]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0124-81462020000100051</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[DETERMINACIÓN DE LA FUNCIÓN PULMONAR MEDIANTE ESPIROMETRÍA EN PACIENTES CON DIAGNÓSTICO CLÍNICO DE ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA (EPOC) DE LA PROVINCIA CENTRO DE BOYACÁ]]></article-title>
<article-title xml:lang="en"><![CDATA[PULMONARY FUNCTION DETERMINATION BY SPIROMETRY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS (COPD) IN BOYACA'S CENTRAL PROVINCE]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas Laverde]]></surname>
<given-names><![CDATA[María del Pilar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Yanguas]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Corredor Gamba]]></surname>
<given-names><![CDATA[Sandra Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Polanía Robayo]]></surname>
<given-names><![CDATA[Alba Yanira]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Molina Franky]]></surname>
<given-names><![CDATA[Jessica Sthepanie]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Roa Cubaque]]></surname>
<given-names><![CDATA[Marcela América]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Boyacá Facultad Ciencias de la Salud Grupo de Investigación Oxigenar]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital San Rafael de Tunja Grupo de Investigación Oxigenar ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Boyacá Facultad Ciencias de la Salud Grupo de Investigación Oxigenar]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Boyacá Facultad Ciencias de la Salud Grupo de Investigación Oxigenar]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad de Boyacá Facultad Ciencias de la Salud Grupo de Investigación Oxigenar]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Universidad de Boyacá Facultad Ciencias de la Salud Grupo de Investigación Oxigenar]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<volume>22</volume>
<numero>40</numero>
<fpage>51</fpage>
<lpage>66</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0124-81462020000100051&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0124-81462020000100051&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0124-81462020000100051&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: La enfermedad pulmonar obstructiva crónica (EPOC) es una patología frecuente, prevenible y tratable, que se caracteriza por síntomas respiratorios y una limitación al flujo aéreo persistente, el cual se debe a anomalías de las vías respiratorias o alveolares causadas generalmente por una exposición a partículas o gases nocivos; su abordaje debe ser integral y la exploración de la función pulmonar se realiza a través de la espirometría forzada. El resultado de la relación VEF1/CVF posbroncodilatador &lt;0,70 confirma la limitación al flujo aéreo, lo cual permite establecer el diagnóstico de la enfermedad.  Objetivo: Determinar mediante espirometría la función pulmonar de pacientes con diagnóstico clínico de EPOC de la Provincia Centro de Boyacá.  Metodología: Estudio de tipo transversal con diseño descriptivo. El tamaño de la muestra fue de 337 pacientes con diagnóstico clínico de EPOC de los 15 municipios que integran la Provincia Centro del departamento de Boyacá. Los datos fueron suministrados por las empresas sociales del Estado de cada municipio. Se realizó análisis univariado a través de medidas de tendencia central, promedios, desviación estándar, porcentajes e intervalos de confianza.  Resultados: La población estudiada estuvo conformada por pacientes con diagnóstico clínico de EPOC caracterizada por ser en su mayoría mujeres, con edad, talla y peso promedio de 72 años, 1,54 m y 62 kg, respectivamente; un porcentaje del 46% de pacientes reportó patrón espirométrico normal, seguido del 33 % que reportaron patrón obstructivo. Del total de pacientes con alteración espirométrica obstructiva, el 16 % presentaron obstrucción leve, seguido del 9 % con obstrucción moderada y severa. Respectivamente. Finalmente, el 33,2 % tienen diagnóstico de EPOC confirmado a través de la espirometría forzada.  Conclusión: La población estudiada contaba con diagnóstico clínico de EPOC; sin embargo, de los 280 pacientes quienes realizaron pruebas de espirometrías pre y posbroncodilatador adecuadas, es decir, que tuvieron calidad (A, B o C), solo el 33 % obtuvo patrón obstructivo leve en mayor proporción, seguido de moderado y grave, lo que significa que solo en ese porcentaje de pacientes se confirmó el diagnóstico de EPOC; los demás reportaron patrones espirométricos normales o restrictivos que están relacionados con otra patología. Lo anterior permite concluir que existe un subregistro en el diagnóstico, puesto que no todos los pacientes con sintomatología relacionada con EPOC tienen la enfermedad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Chronic obstructive pulmonary disease (COPD) is a frequent disease, preventable and treatable, characterized by long-term breathing problems and poor airflow, and caused by anomalies in the respiratory conducts, or alveolars, after continuous exposure to particles or harmful gases. Its approach must be integral. The pulmonary function exploration is made by reinforced spirometry and the results from post-bronchodilator FEV1/FVC &lt; 0.70 confirm the airflow limitation and the diagnoses.  Objective: To determine, by spirometry, the pulmonary function of COPD's patience in Boyaca's central province.  Methodology: Transversal study with a descriptive design. The sample's size was 337 COPD patients from 15 Boyaca's municipalities from the central province. Data were given by State Social Enterprises. A univariate analysis was carried out through measures of central tendency, averages, standard deviation, percentages, and confidence intervals.  Results: Studied population was made of COPD patients, mostly women, with 72 years, 1,54 m, and 62 kg on average. 46% of patients reported a spirometry normal pattern and 33% an obstructive pattern of which 16% present a mild obstruction and 9% moderate and severe obstruction. Finally, 32% are COPDS diagnosed with reinforced spirometry.  Conclusion: Studied population was COPD's diagnosed, but, from 280 patients who had spirometry, pre- and post-bronchodilator, (A, B, or C), only 33% had a mild obstructive pattern, followed by moderated and severe. That means, only that percentage confirmed COPD's diagnose, others had normal or restrictive obstruction patterns related to other pathologies. So, it can be confirmed the existence of a sub-register, because not all patients with COPD's symptoms already have the disease.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[diagnóstico]]></kwd>
<kwd lng="es"><![CDATA[enfermedad pulmonar obstructiva crónica]]></kwd>
<kwd lng="es"><![CDATA[espirometría]]></kwd>
<kwd lng="en"><![CDATA[Chronic obstructive pulmonary disease]]></kwd>
<kwd lng="en"><![CDATA[diagnosis]]></kwd>
<kwd lng="en"><![CDATA[spirometry]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eisner]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Anthonissen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Coultas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Am J Respiratory Critical Care Med]]></source>
<year>2010</year>
<volume>182</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>693-718</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salvi]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic obstructive pulmonary disease in non-smokers]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2009</year>
<volume>347</volume>
<numero>9691</numero>
<issue>9691</issue>
<page-range>733-43</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Asociación Lationamericana de Tórax</collab>
<source><![CDATA[Departamento EPOC. Recomendaciones para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica (EPOC)]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buist]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[McBurnie]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International variation in the prevalence study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2007</year>
<volume>307</volume>
<numero>9589</numero>
<issue>9589</issue>
<page-range>741-50</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>Minsalud, Dirección de Promoción y Prevención</collab>
<source><![CDATA[Subdirección de enfermedades no transmisibles. Enfermedad pulmonar obstructiva crónica (EPOC)]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mannino]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994]]></article-title>
<source><![CDATA[Archives of Internal Medicine]]></source>
<year>2000</year>
<volume>160</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1683-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buist]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2007</year>
<volume>370</volume>
<numero>9589</numero>
<issue>9589</issue>
<page-range>741-50</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halbert]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global burden of COPD: systematic review and meta-analysis]]></article-title>
<source><![CDATA[European Respiratory Journal]]></source>
<year>2006</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>523-32</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menezes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic obstructive pulmonary disease in Ave Latin American cities (the Platino study): a prevalence study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2005</year>
<volume>366</volume>
<numero>9500</numero>
<issue>9500</issue>
<page-range>1875-81</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Iniciativa Global para la enfermedad pulmonar obstructiva crónica</collab>
<source><![CDATA[Guía de bolsillo para el diagnóstico, manejo y prevención de la EPOC: una guía para profesionales sanitarios]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Global Initiative for Chronic Obstructive Lung Disease</collab>
<source><![CDATA[Global strategy for diagnosis, management, and prevention of COPD Updated 2010]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>Guías Asociación Latinoamericana de Tórax (ALAT)</collab>
<source><![CDATA[Recomendaciones para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica (EPOC)]]></source>
<year>2014</year>
<publisher-name><![CDATA[La Asociación]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muela Molinero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Actualización de guías en la EPOC GOLD 2011 Gesepoc]]></source>
<year></year>
<publisher-name><![CDATA[Servicio de Medicina Interna. Hospital Universitario de León]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nishimura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2002</year>
<volume>121</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1434-40</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soler-Cataluna]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2005</year>
<volume>60</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>925-931.55</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connors]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcomes following acute exacerbation of severe chronic obstructive lung disease. The Support investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)]]></article-title>
<source><![CDATA[American Journal Respiratory Critical Care Medicine]]></source>
<year>1996</year>
<volume>154</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>959-67</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montserrat]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados a la mortalidad global en los pacientes diagnosticados de enfermedad pulmonar obstructiva crónica]]></article-title>
<source><![CDATA[Atención Primaria]]></source>
<year>2015</year>
<volume>47</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>498-504</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halbert]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interpreting COPD prevalence estimates: ¿what is the true burden of disease?]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2003</year>
<numero>123</numero>
<issue>123</issue>
<page-range>1684-92</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paisán]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de la enfermedad pulmonar obstructiva crónica en una parroquia venezolana]]></article-title>
<source><![CDATA[Rev Cub de Med Gen Integr]]></source>
<year>2006</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad pulmonar obstructiva: diferencias entre hombres y mujeres]]></article-title>
<source><![CDATA[Medicina]]></source>
<year>2012</year>
<numero>72</numero>
<issue>72</issue>
<page-range>207-15</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Salud autopercibida, apoyo social y familiar de los pacientes con enfermedad pulmonar obstructiva crónica]]></article-title>
<source><![CDATA[Medifam]]></source>
<year>2001</year>
<volume>11</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>530-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pineda]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida en pacientes con enfermedad pulmonar obstructiva. Medellín. 2014]]></article-title>
<source><![CDATA[Revista Univ. Salud]]></source>
<year>2016</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>482-93</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Temas de medicina interna]]></source>
<year>2005</year>
<edition>4</edition>
<publisher-loc><![CDATA[Ciudad de La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borrows]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The course and prognosis of chronic airways obstruction in a sample from the general population]]></article-title>
<source><![CDATA[N Engl. J Med]]></source>
<year>2001</year>
<numero>317</numero>
<issue>317</issue>
<page-range>13</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dewar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peak inspiratory flow through torbuhaler in chronic obstructive airways diseases]]></article-title>
<source><![CDATA[Am Revista Respir Med]]></source>
<year>1999</year>
<volume>93</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>342-4</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molfino]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento de pacientes con enfermedad pulmonar obstructiva crónica (EPOC) por médicos clínicos generales]]></article-title>
<source><![CDATA[Medicina]]></source>
<year>2004</year>
<volume>64</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>445-54</page-range><publisher-loc><![CDATA[B. Aires ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voelkel]]></surname>
<given-names><![CDATA[NF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Raising awareness of COPD in primary care]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2000</year>
<numero>11</numero>
<issue>11</issue>
<page-range>S372-5</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[De la Rosa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Naberan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lamban]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gobartt]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of spirometry and patterns of prescribing in COPD in primary care]]></article-title>
<source><![CDATA[Respir Med]]></source>
<year>2007</year>
<numero>101</numero>
<issue>101</issue>
<page-range>1753-60</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caramori]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bettoncelli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tosatto]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Arpinelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Visona]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Intermezzi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Monaldi Arch Chest Dis]]></source>
<year>2005</year>
<numero>63</numero>
<issue>63</issue>
<page-range>6-12</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buffels]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Degryse]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Liistro]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic certainty, comorbidity and medication in a primary care population with presumed airway obstruction: The Didasco 2 Study]]></article-title>
<source><![CDATA[Primary Care Respir J]]></source>
<year>2009</year>
<numero>18</numero>
<issue>18</issue>
<page-range>34-40</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Algunos aspectos clínicos y espirométricos en la enfermedad pulmonar obstructiva crónica]]></article-title>
<source><![CDATA[Revista Archivo Médico de Camagüey]]></source>
<year>2008</year>
<volume>12</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
